terminal betWe investated the ability of BET bromodomain small molecule inhibitors to reduce the β-cell response to the proinflammatory cytokine interleukin 1 betaDiscussion. This study describes a mechanism by which inhibition of a specific BET bromodomain reduces NOS2 transcription and β